Company Description
Catheter Precision, Inc. designs, manufactures, and sells medical technologies for the field of cardiac electrophysiology (EP) in the United States.
The company’s lead product is View into Ventricular Onset System, a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures.
It also provides LockeT, a suture retention device that temporarily secure sutures and aid clinicians in locating and removing sutures; and Amigo Remote Catheter System, a robotic arm that serves as a catheter control device.
The company sells it products through distribution partners, independent sales agents, and direct employees.
Catheter Precision, Inc. is based in Fort Mill, South Carolina.
| Country | United States |
| Founded | 2002 |
| IPO Date | Aug 30, 2018 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 14 |
| CEO | David Jenkins |
Contact Details
Address: 1670 Highway 160 West, Suite 205 Fort Mill, South Carolina 29708 United States | |
| Phone | 973-691-2000 |
| Website | catheterprecision.com |
Stock Details
| Ticker Symbol | VTAK |
| Exchange | NYSEAMERICAN |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001716621 |
| ISIN Number | US74933X3026 |
| Employer ID | 38-3661826 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| David A. Jenkins | Chief Executive Officer and Executive Chairman |
| Margrit Thomassen CPA | Interim Chief Financial Officer and Secretary |
| Missiaen Huck | Chief Operating Officer |
| Marie-Claude Jacques | Chief Commercial Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Dec 4, 2024 | EFFECT | Notice of Effectiveness |
| Nov 25, 2024 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Nov 25, 2024 | DEF 14A | Other definitive proxy statements |
| Nov 21, 2024 | S-1 | General form for registration of securities under the Securities Act of 1933 |
| Nov 15, 2024 | PRE 14A | Other preliminary proxy statements |
| Nov 14, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Nov 14, 2024 | 8-K | Current Report |
| Nov 14, 2024 | 10-Q | Quarterly Report |
| Nov 13, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Nov 4, 2024 | 8-K/A | [Amend] Current report |